High throughput chemical library screening identifies a novel p110-δ inhibitor that potentiates the anti-myeloma effect of bortezomib

Por Malek, Ehsan, Driscoll, James J.
Publicado no Oncotarget (2016)

MicroRNAs in Brain Metastases: Potential Role as Diagnostics and Therapeutics

Por Alsidawi, Samer, Malek, Ehsan, Driscoll, James J.
Publicado em 2014

Correlation of long non-coding RNA expression with metastasis, drug resistance and clinical outcome in cancer

Por Malek, Ehsan, Jagannathan, Sajjeev, Driscoll, James J.
Publicado no Oncotarget (2014)

Identification of Long Non-Coding RNAs Deregulated in Multiple Myeloma Cells Resistant to Proteasome Inhibitors

Por Malek, Ehsan, Kim, Byung-Gyu, Driscoll, James J.
Publicado no Genes (Basel) (2016)

Timing Embryo Preservation for a Patient with High-Risk Newly Diagnosed Acute Myeloid Leukemia

Por Ye, Rebecca, Tomlinson, Benjamin, de Lima, Marcos, Malek, Ehsan
Publicado no Case Rep Hematol (2018)

Allograft for Myeloma: Examining Pieces of the Jigsaw Puzzle

Por Malek, Ehsan, El-Jurdi, Najla, Kröger, Nicolaus, de Lima, Marcos
Publicado no Front Oncol (2017)

Bortezomib induces AMPK-dependent autophagosome formation uncoupled from apoptosis in drug resistant cells

Por Jaganathan, Sajjeev, Malek, Ehsan, Vallabhapurapu, Subrahmanya, Vallabhapurapu, Sivakumar, Driscoll, James J.
Publicado no Oncotarget (2014)

Molecular chaperone GRP78 enhances aggresome delivery to autophagosomes to promote drug resistance in multiple myeloma

Por Abdel Malek, Mohamed A.Y., Jagannathan, Sajjeev, Malek, Ehsan, Sayed, Douaa M., Elgammal, Sahar A., Abd El-Azeem, Hanan G., Thabet, Nabila M., Driscoll, James J.
Publicado no Oncotarget (2014)